Singapore Ophthalmic Drug Delivery Systems Market Size & Outlook
Singapore ophthalmic drug delivery systems market, 2018-2030 (US$M)
Related Markets
Singapore ophthalmic drug delivery systems market highlights
- The Singapore ophthalmic drug delivery systems market generated a revenue of USD 58.0 million in 2021 and is expected to reach USD 126.8 million by 2030.
- The Singapore market is expected to grow at a CAGR of 9.1% from 2022 to 2030.
- In terms of segment, eye drops was the largest revenue generating technology in 2021.
- Punctal plugs is the most lucrative technology segment registering the fastest growth during the forecast period.
Ophthalmic drug delivery systems market data book summary
| Market revenue in 2021 | USD 58.0 million |
| Market revenue in 2030 | USD 126.8 million |
| Growth rate | 9.1% (CAGR from 2021 to 2030) |
| Largest segment | Eye drops |
| Fastest growing segment | Punctal plugs |
| Historical data | 2017 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Eye drops, Contact lenses, Punctal plugs, Episcleral Implants, Intravitreal Implants, Injectable Particulate Systems, Iontophoresis, Micro-electromechanical, Nano careers, Nano microparticles, Microneedles, Hydrogels, Other Technology |
| Key market players worldwide | Ocular Therapeutix Inc, Allergan, Santen Pharmaceutical Co Ltd, Clearside Biomedical Inc, Oculis Holding AG, Bausch Health Companies Inc, AptarGroup Inc |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.5% of the global ophthalmic drug delivery systems market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ophthalmic drug delivery systems market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 419.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Drug Delivery Systems Market Scope
Ophthalmic Drug Delivery Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore ophthalmic drug delivery systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drug delivery systems market will help companies and investors design strategic landscapes.
Eye drops was the largest segment with a revenue share of 20.34% in 2025. Horizon Databook has segmented the Singapore ophthalmic drug delivery systems market based on eye drops, contact lenses, punctal plugs, episcleral implants, intravitreal implants, injectable particulate systems, iontophoresis, micro-electromechanical, nano careers, nano microparticles, microneedles, hydrogels, other technology covering the revenue growth of each sub-segment from 2018 to 2030.
- Singapore Ophthalmic Drug Delivery Systems Technology Outlook (Revenue, USD Million, 2018-2030)
- Eye drops
- Contact lenses
- Punctal plugs
- Episcleral Implants
- Intravitreal Implants
- Injectable Particulate Systems
- Iontophoresis
- Micro-Electromechanical
- Nano careers
- Nano microparticles
- Microneedles
- Hydrogels
- Others
- Singapore Ophthalmic Drug Delivery Systems Delivery Route Outlook (Revenue, USD Million, 2018-2030)
- Intraocular
- Intravitreal
- Intracameral
- Singapore Ophthalmic Drug Delivery Systems Production Technology Outlook (Revenue, USD Million, 2018-2030)
- Electrospinning
- 3D printing
- Extrusion
- Formulation
- Micro patterning
- Compression molding
- Others
- Singapore Ophthalmic Drug Delivery Systems Material Outlook (Revenue, USD Million, 2018-2030)
- Liposomes
- Collagen
- PLA-PEG
- PDO/PVA
- Hydrogels
- TMC
- Polyorthoesters
- PLGA
- Polycaprolactone
- Fatty acids
- Others
Reasons to subscribe to Singapore ophthalmic drug delivery systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore ophthalmic drug delivery systems market databook
-
Our clientele includes a mix of ophthalmic drug delivery systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore ophthalmic drug delivery systems market, including forecasts for subscribers. This country databook contains high-level insights into Singapore ophthalmic drug delivery systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore Ophthalmic Drug Delivery Systems Market Share, 2025 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
